OUL35

CAS No. 6336-34-1

OUL35( NSC39047 )

Catalog No. M24643 CAS No. 6336-34-1

OUL35 is a selective PARP-10 inhibitor, and small-molecule ARTD10 inhibitor. OUL35 has been shown to rescue cells from ARTD10-induced cell death.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 47 In Stock
10MG 77 In Stock
25MG 149 In Stock
50MG 237 In Stock
100MG 368 In Stock
500MG 872 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    OUL35
  • Note
    Research use only, not for human use.
  • Brief Description
    OUL35 is a selective PARP-10 inhibitor, and small-molecule ARTD10 inhibitor. OUL35 has been shown to rescue cells from ARTD10-induced cell death.
  • Description
    OUL35 is a selective PARP-10 inhibitor, and small-molecule ARTD10 inhibitor. OUL35 has been shown to rescue cells from ARTD10-induced cell death.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC39047
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    PARP
  • Recptor
    ARTD10|PARP10
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6336-34-1
  • Formula Weight
    256.26
  • Molecular Formula
    C14H12N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    C1=CC(=CC=C1C(=O)N)OC2=CC=C(C=C2)C(=O)N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tripathi P , Tian Y M , Komnig D . The mono-ADP-ribosyltransferase ARTD10 regulates the voltage-gated K+ channel Kv1.1 through protein kinase C delta[J]. BMC Biology, 2020.
molnova catalog
related products
  • Tripalmitin

    Tripalmitin is a triacylglycerol found in dietary fats. Tripalmitin increases body weight and plasma LDL levels and reduces hepatic LDL receptor mRNA levels in hamsters fed a diet enriched with it.

  • Talazoparib

    Talazoparib (BMN 673) is a novel PARP inhibitor with IC50 of 0.58 nM.

  • AZD5305

    AZD5305 is a potent, selective and oral active PARP inhibitor.